Log in to save to my catalogue

Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated am...

Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated am...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_49781534e05f4b11946b910dc6606509

Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of bla TEM-1B

About this item

Full title

Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of bla TEM-1B

Publisher

England: Nature Portfolio

Journal title

Nature communications, 2020-10, Vol.11 (1), p.4915-9

Language

English

Formats

Publication information

Publisher

England: Nature Portfolio

More information

Scope and Contents

Contents

A phenotype of Escherichia coli and Klebsiella pneumoniae, resistant to piperacillin/tazobactam (TZP) but susceptible to carbapenems and 3rd generation cephalosporins, has emerged. The resistance mechanism associated with this phenotype has been identified as hyperproduction of the β-lactamase TEM. However, the mechanism of hyperproduction due to g...

Alternative Titles

Full title

Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of bla TEM-1B

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_49781534e05f4b11946b910dc6606509

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_49781534e05f4b11946b910dc6606509

Other Identifiers

E-ISSN

2041-1723

DOI

10.1038/s41467-020-18668-2

How to access this item